Cardiofocus, Inc.

Other Technology · Marlborough, Massachusetts

FinTech

Cardiofocus, Inc. is a other technology company based in Marlborough, Massachusetts. It has raised at least $153.2 million across 9 known rounds, of which $124.0 million was reported to the SEC on 9 Form D filings, most recently in 2023.

CardioFocus provides electrophysiologists with innovative tools for the treatment of atrial fibrillation.

Total raised
$153.2M
13 rounds
$153.2M filed with the SEC
DateRoundAmountRaised to dateLead investorSource
2023-02-24$27.2M$153.2MSEC Form D
2022-04-12$4.0M$126.1MSEC Form D
2020-07-20$12.0M$122.1MSEC Form D
2019-05-20$8.0M$110.0MSEC Form D
2018-04-18+1 amd$13.0M$102.0MSEC Form D
2017-03-01$20.2M$89.0MSEC Form D
2016-05-18$8.0M$68.9MSEC Form D
2015-01-06$31.7M$60.9MSEC Form D
2014-11-13$2.3M$29.2MSEC Form D
2014-05-09$2.4M$26.9MSEC Form D
2011-02-24$13.6M$24.5MSEC Form D
2010-04-20$5.0M$10.9MSEC Form D
2009-06-25$5.9M$5.9MSEC Form D

SEC rows are Form D filings, where the amount is what was actually sold and amendments update a round rather than adding one. Press rows are split between company-issued releases or wires and editorial or third-party coverage. The total is therefore a floor: a round nobody reported is a round we cannot see. A buyout or control change appears in the timeline but is never added to the total: that money goes to shareholders, not into the company.

Form D is the notice a company files with the SEC when it sells securities without registering them. It reports the amount sold, not a valuation. Figures here are what the filing says. Where a filing is silent, the field is left blank rather than estimated. “Total raised” adds press-reported rounds that never appear in a filing, so it is a floor rather than an audited sum: press amounts are the figures the company announced, and a round nobody reported is a round we cannot see.